HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autocrine inhibitory influences of alpha-melanocyte-stimulating hormone in malignant pleural mesothelioma.

Abstract
Malignant pleural mesothelioma is a highly aggressive tumor arising from the mesothelial cells that line the pleural cavities. This tumor is resistant to most conventional anticancer treatments and appears to be very sensitive to growth-promoting influences of cytokines and growth factors. Identification of natural inhibitory pathways that control growth should aid discovery of novel therapeutic approaches. We hypothesized that alpha-melanocyte-stimulating hormone (alpha-MSH), which is produced by many cell types and antagonizes cytokines and growth factors, could be an endogenous inhibitory molecule in mesothelioma. Twelve mesothelioma cell lines were established from pleural effusions of patients with malignant mesothelioma. Mesothelioma cells were found to express mRNA for proopiomelanocortin and its processing enzymes; release alpha-MSH peptide into supernatants; and express melanocortin 1 receptor (MC1R), the high-affinity receptor for alpha-MSH. Immunoneutralization of MC1R in the cell lines enhanced expression of interleukin-8 (IL-8), IL-6, and transforming growth factor-beta. These molecules promote mesothelioma proliferation and are considered therapeutic targets in this tumor. Coincubation of mesothelioma cells with synthetic alpha-MSH significantly reduced cell proliferation. The present research shows an autocrine-inhibitory circuit based on alpha-MSH and its receptor MC1R. Activation of MC1R by selective peptides or peptidomimetics might provide a novel strategy to reduce mesothelioma cell proliferation by taking advantage of this endogenous inhibitory circuit.
AuthorsAnna Catania, Gualtiero Colombo, Andrea Carlin, Letizia Garofalo, Stefano Gatti, Roberto Buffa, Nadia Carboni, Lorenzo Rosso, Luigi Santambrogio, Luigi Cantalamessa, James M Lipton
JournalJournal of leukocyte biology (J Leukoc Biol) Vol. 75 Issue 2 Pg. 253-9 (Feb 2004) ISSN: 0741-5400 [Print] England
PMID14576363 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Peptide Fragments
  • RNA, Neoplasm
  • Receptor, Melanocortin, Type 1
  • alpha-MSH
  • Pro-Opiomelanocortin
Topics
  • Autocrine Communication (physiology)
  • Cell Division
  • Cytokines (biosynthesis)
  • Dose-Response Relationship, Drug
  • Humans
  • Immunohistochemistry
  • Mesothelioma (metabolism, pathology)
  • Peptide Fragments (pharmacology)
  • Pleural Neoplasms (metabolism, pathology)
  • Pro-Opiomelanocortin (genetics)
  • RNA, Neoplasm (analysis)
  • Receptor, Melanocortin, Type 1 (analysis)
  • Tumor Cells, Cultured
  • alpha-MSH (chemistry, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: